BioSpace News Archive

MaxCyte, Inc. today announced that, on April 11, 2022, the Compensation Committee of MaxCyte’s Board of Directors granted stock options to purchase (i) an aggregate of 54,000 share.

QOL Medical, LLC announced today it has selected Optum Frontier Therapies as its new pharmacy partner to support CSID patients nationwide being treated with Sucraid® (sacrosidase) Oral Solution.

LeMaitre Vascular, Inc. announced that it will release its first quarter 2022 financial results on Thursday, April 28, 2022, after the market close.

“We are making significant progress advancing our pipeline of treatments for ocular disease,” said Brian M. Strem, Ph.D., President and Chief Executive Officer of Kiora.

Integrity Implants Inc. d/b/a Accelus and CHP Merger Corp. announced that the companies have mutually agreed to terminate, effective immediately, the previously announced business combination agreement dated November 14, 2021 as a result of market conditions.

Albany NY, United States: Aesthetic implants are used for cosmetic as well as reconstructive procedures.

Albany NY, United States: Bone Bone-anchored hearing aids are surgically implantable devices designed to treat hearing loss.

DUBAI, United Arab Emirates, Sales of smart pill boxes and bottles are likely to reach around 800 thousand in 2019.

The oral cancer treatment market has been projected to grow at a significant speed in the foreseeable years.

Palantir Technologies Inc. (NYSE:PLTR) today announced an extension and expansion of its work with the U.S. Centers for Disease Control and Prevention (CDC) through the outbreak response and disease surveillance solution for the Data Collation and Integration for Public Health Event Response (DCIPHER) Program.